Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Protein Kinase C Inhibitor LXS196

Known as: LXS196, PKC Inhibitor LXS196 
An orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We assessed the safety, tolerability, PK, PD and efficacy of the PKC inhibitor LXS196 in patients with metastatic uveal melanoma… Expand
Is this relevant?
2019
2019
We assessed the safety, tolerability, PK, PD and efficacy of the PKC inhibitor LXS196 in patients with metastatic uveal melanoma… Expand
Is this relevant?